Director - Neuroscience

Eli Lilly Eli Lilly · Pharma · Indianapolis, IN +1

Seeking a scientific laboratory leader with a solid background in Neuroscience to join the Psychiatry, Pain and Neuronal Health Team within Neuroscience Discovery Group. The role involves leading a laboratory, developing preclinical in vivo biomarker assays, and contributing to cross-functional teams focused on developing novel medicines for neurological and psychiatric disorders.

What you'd actually do

  1. Supervise a group of dedicated laboratory neuroscientists.
  2. Lead cross-functional teams in preclinical drug development phase.
  3. Present data and conclusions to leadership and decision makers in a clear, balanced, and compelling manner.
  4. Identify, develop, and implement innovative approaches to add functional capabilities and gain new insights into psychiatric and neurological disease biology, target engagement and pharmacodynamics.

Skills

Required

  • PhD in Biology, Biochemistry Neuroscience, Neurophysiology, or related scientific discipline with 10+ years industry or academic experience beyond any postdoctoral positions.
  • Alternatively, a Masters degree in Neuroscience, Neurophysiology, or related scientific discipline with 20+ years industry or academic work experience leading a laboratory and leading discovery projects through preclinical development
  • Clear understanding of pharmacology principles and measures of target engagement _ex vivo_ or _in vivo_ to drive human dose projections.
  • Demonstrated ability to lead a cross-functional team and translate preclinical biomarkers to clinical development.
  • Excellent communication and presentation of scientific skills.
  • Ability to work both independently and in cross-functional teams, as well as influencing beyond direct reports.
  • Demonstrated expertise in Neuroscience research as evidenced by peer reviewed publication record.

Nice to have

  • Experience preparing document for regulatory filings.

What the JD emphasized

  • critical and robust decisional data
  • preclinical in vivo biomarker assays
  • translational early clinical phase development
  • regulatory filings